Drug
Mhb034c For
Mhb034c For: highest development phase Phase 1/2, developed by Minghui Pharmaceutical (Shanghai) LTD. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Minghui Pharmaceutical (Shanghai) LTD
Trials
| Drug | Phase | Indication |
|---|---|---|
| MHB034C for Injection NCT07928570 | Phase 1/2 | Advanced Malignant Solid Tumor |
Latest
No recent events.
Follow Mhb034c For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.